Liquidia (NASDAQ:LQDA) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Liquidia (NASDAQ:LQDA) from a buy rating to a hold rating in a research report released on Saturday morning,Wall Street Zen reports.

A number of other research analysts have also commented on the company. Piper Sandler set a $129.00 price objective on Liquidia in a report on Friday, July 24th. Royal Bank Of Canada set a $130.00 price target on shares of Liquidia in a research note on Friday, July 24th. BTIG Research raised their price target on shares of Liquidia from $109.00 to $111.00 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Lifesci Capital cut shares of Liquidia from an “outperform” rating to a “hold” rating and set a $90.00 price objective for the company. in a research note on Wednesday, August 12th. Finally, Bank of America boosted their price objective on shares of Liquidia from $79.00 to $92.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $98.08.

Liquidia Stock Down 2.1%

Liquidia stock opened at $65.31 on Friday. The company’s 50-day moving average price is $77.19 and its two-hundred day moving average price is $59.67. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. The stock has a market cap of $5.85 billion, a P/E ratio of 47.67 and a beta of 0.53. Liquidia has a twelve month low of $21.15 and a twelve month high of $93.61.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Wednesday, August 12th. The company reported $0.74 EPS for the quarter, missing the consensus estimate of $0.76 by ($0.02). The firm had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. Liquidia’s revenue for the quarter was up 1842.1% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.49) EPS. As a group, analysts expect that Liquidia will post 2.57 EPS for the current year.

Insider Activity

In other news, CAO Dana Boyle sold 1,600 shares of the business’s stock in a transaction that occurred on Monday, July 27th. The shares were sold at an average price of $87.53, for a total value of $140,048.00. Following the completion of the transaction, the chief accounting officer directly owned 167,919 shares in the company, valued at approximately $14,697,950.07. The trade was a 0.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katherine Rielly-Gauvin sold 18,393 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $72.23, for a total transaction of $1,328,526.39. Following the sale, the director directly owned 44,637 shares of the company’s stock, valued at approximately $3,224,130.51. This trade represents a 29.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 705,027 shares of company stock valued at $54,473,044. Company insiders own 25.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in LQDA. WINTON GROUP Ltd bought a new stake in Liquidia during the second quarter worth $335,000. Arizona State Retirement System increased its stake in shares of Liquidia by 5.4% in the 2nd quarter. Arizona State Retirement System now owns 17,627 shares of the company’s stock valued at $1,405,000 after purchasing an additional 900 shares during the last quarter. Nykredit A S bought a new position in shares of Liquidia in the 2nd quarter valued at $177,000. Corient Private Wealth LP acquired a new position in shares of Liquidia during the 2nd quarter worth $758,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Liquidia during the 2nd quarter worth $1,236,000. 64.54% of the stock is currently owned by institutional investors and hedge funds.

About Liquidia

Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing medicines for patients with serious cardiopulmonary conditions, including pulmonary arterial hypertension (PAH). The company is headquartered in Research Triangle Park, North Carolina, and serves healthcare providers and patients primarily in the United States.

Liquidia’s lead product is Yutrepia, an inhaled formulation of treprostinil designed for the treatment of PAH. The company has also developed treprostinil injection products and is pursuing additional therapies for rare cardiopulmonary diseases.